Molecular Microbiology in Osteo-arthritis Infection (MOLOS)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov Identifier:
NCT01193803
First received: April 1, 2010
Last updated: May 30, 2014
Last verified: May 2014
  Purpose

Osteoarticular infections are painful and disabling diseases that require antimicrobial treatment adapted to the microorganisms implicated. Microbiological cultures are currently regarded as the reference for identification of pathogenic bacteria. However, the sensitivity of these cultures is very variable and depends both on the context in which clinical samples are taken, and on the pathogen involved. The rate of detection varies according to infection type: from 50 to 70% for infectious spondylodiscitis, 65 to 95% for prosthetic joint infections, 50% for gonococcal arthritis and 90% for non-gonococcal arthritis. The aim of the study is to evaluate the diagnostic performances of microbiological cultures and molecular methods in case of osteoarticular infections. The gold standard will be established by an expert group of osteoarticular infection (composed by a bacteriologist, a radiologist, a surgeon, an anatomy-pathologist and a rheumatologist), which established the final diagnosis of infected or not infected patients.


Condition Intervention
Osteoarticular Infections
Procedure: Microbiological cultures and Molecular biology

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Interest of Molecular Biology for Diagnostic of Osteo-arthritis Infections. EE Observational Prospective Study

Resource links provided by NLM:


Further study details as provided by Assistance Publique - Hôpitaux de Paris:

Primary Outcome Measures:
  • Prosthetic Joint Infections, Vertebral Osteomyelitis and Septic arthritis: Frequency of detection with classical bacteriological methods and molecular methods [ Time Frame: Day 0 ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Time of returned results by one or the other of the techniques [ Time Frame: up to 90 days ] [ Designated as safety issue: No ]

Biospecimen Retention:   Samples Without DNA

Detection of bacteria will be performed on sample provided from the osteoarticular infections like articular fluids, synovial biopsies, bone biopsies, intervertebral disc, paravertebral or epidural abscess, articular capsul...


Enrollment: 229
Study Start Date: October 2008
Study Completion Date: June 2012
Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Spondylodiscitis control group
Patients needing vertebral biopsy looking for tumoral etiology
Procedure: Microbiological cultures and Molecular biology

Biological/Vaccine: Microbiological cultures and Molecular Biology Bacteriological procedures: All solid specimens will be crushed using a mechanic apparatus. Direct examination and cultures will be performed according to the guidelines applied for osteoarticular infections. Cultures and subcultures will be incubated for 15 days to 3 months for Mycobacteria.

Molecular procedures: DNA extraction will be based on Boom's method (QIAGEN kit and EZ1 BioRobot). Detections of bacteria will be performed by amplification and sequencing of the 16S rRNA gene. Some specific detections as the detection of Staphylococcus sp. and Mycobacterium tuberculosis will be added to this protocol.

Prosthetic Joint Infection control group
Patients with primary prosthetic arthrosis surgery
Procedure: Microbiological cultures and Molecular biology

Biological/Vaccine: Microbiological cultures and Molecular Biology Bacteriological procedures: All solid specimens will be crushed using a mechanic apparatus. Direct examination and cultures will be performed according to the guidelines applied for osteoarticular infections. Cultures and subcultures will be incubated for 15 days to 3 months for Mycobacteria.

Molecular procedures: DNA extraction will be based on Boom's method (QIAGEN kit and EZ1 BioRobot). Detections of bacteria will be performed by amplification and sequencing of the 16S rRNA gene. Some specific detections as the detection of Staphylococcus sp. and Mycobacterium tuberculosis will be added to this protocol.

Septic arthritis control group
Arthrosic patients needing evacuating articular punction with leucocytes infiltration less than 1000 /mm3
Procedure: Microbiological cultures and Molecular biology

Biological/Vaccine: Microbiological cultures and Molecular Biology Bacteriological procedures: All solid specimens will be crushed using a mechanic apparatus. Direct examination and cultures will be performed according to the guidelines applied for osteoarticular infections. Cultures and subcultures will be incubated for 15 days to 3 months for Mycobacteria.

Molecular procedures: DNA extraction will be based on Boom's method (QIAGEN kit and EZ1 BioRobot). Detections of bacteria will be performed by amplification and sequencing of the 16S rRNA gene. Some specific detections as the detection of Staphylococcus sp. and Mycobacterium tuberculosis will be added to this protocol.

Spondylodiscitis case group
Patients suspected of Discitis and/or Vertebral Osteomyelitis is defined by the need of spinal biopsy in infectious context.
Procedure: Microbiological cultures and Molecular biology

Biological/Vaccine: Microbiological cultures and Molecular Biology Bacteriological procedures: All solid specimens will be crushed using a mechanic apparatus. Direct examination and cultures will be performed according to the guidelines applied for osteoarticular infections. Cultures and subcultures will be incubated for 15 days to 3 months for Mycobacteria.

Molecular procedures: DNA extraction will be based on Boom's method (QIAGEN kit and EZ1 BioRobot). Detections of bacteria will be performed by amplification and sequencing of the 16S rRNA gene. Some specific detections as the detection of Staphylococcus sp. and Mycobacterium tuberculosis will be added to this protocol.

Prosthetic Joint Infection case group
Patients suspected of Prosthetic Joint Infection defined by the need of surgical revision for diagnostic or therapeutic aiming in infectious context.
Procedure: Microbiological cultures and Molecular biology

Biological/Vaccine: Microbiological cultures and Molecular Biology Bacteriological procedures: All solid specimens will be crushed using a mechanic apparatus. Direct examination and cultures will be performed according to the guidelines applied for osteoarticular infections. Cultures and subcultures will be incubated for 15 days to 3 months for Mycobacteria.

Molecular procedures: DNA extraction will be based on Boom's method (QIAGEN kit and EZ1 BioRobot). Detections of bacteria will be performed by amplification and sequencing of the 16S rRNA gene. Some specific detections as the detection of Staphylococcus sp. and Mycobacterium tuberculosis will be added to this protocol.

Septic arthritis case group
Patients suspected of Septic arthritis without prosthesis were defined by the need of synovial punction and/or biopsy
Procedure: Microbiological cultures and Molecular biology

Biological/Vaccine: Microbiological cultures and Molecular Biology Bacteriological procedures: All solid specimens will be crushed using a mechanic apparatus. Direct examination and cultures will be performed according to the guidelines applied for osteoarticular infections. Cultures and subcultures will be incubated for 15 days to 3 months for Mycobacteria.

Molecular procedures: DNA extraction will be based on Boom's method (QIAGEN kit and EZ1 BioRobot). Detections of bacteria will be performed by amplification and sequencing of the 16S rRNA gene. Some specific detections as the detection of Staphylococcus sp. and Mycobacterium tuberculosis will be added to this protocol.


Detailed Description:

Background: Osteoarticular infections are painful and disabling diseases that require antimicrobial treatment adapted to the microorganisms implicated. Microbiological cultures are currently regarded as the reference for identification of pathogenic bacteria and it seems that the microbiological cultures are sufficient in most cases to establish the diagnosis. However, the sensitivity of these cultures is very variable and depends both on the context in which clinical samples are taken, and on the pathogen involved. In addition, previous experimental data show that molecular methods could produce a diagnosis missing by conventional cultures. Main objective: The aim of the study is to evaluate the diagnostic performances of microbiological cultures and molecular method by considering for the definition of cases an accumulation of clinical, radiological and biological arguments usually used to establish the diagnosis of bone and joint infections. The discordance of the two methods will be secondary classified by an expert group of osteoarticular infection (composed by a bacteriologist, a radiologist, a surgeon, a anatomy-pathologist and a rheumatologist).Tested hypothesis:Interest of molecular methods for the diagnosis of osteoarticular infections.Secondary objective:Quantification of the delay of the results obtained by the two methods Study design: · One centre specialized in osteoarticular infections· Observational prospective study· Two methods of diagnosis: cultures and molecular methods· An expert group Included patients and number of patients: Total of 284 patients composed by 194 cases and 90 controlsIncluded patients (n=194) will all have a suspected diagnosis of osteoarticular infections included discitis, septic arthritis and prosthetic joint infection defined by inclusions criteria.Results of the included patients will be compared to those obtained from the group of control patients (n=90).Protocol of duration: Study duration is 6 months for each patientThe protocol duration is planned for 2 yearsProcedures:All samples will be treated with the same procedure - Samples (synovial fluids, biopsies, ..) will be recovered either during surgery, by puncture aspiration at the bedside, or by guided ultrasonography, all under sterile conditions (mask, sterile gloves, cautious skin preparation and towelling) and transported to the Bacteriology department in sterile tubes without additional substrate in less than 12 hours. - Bacteriological procedures will be performed according to the guidelines applied for osteoarticular infection · Liquid samples: erythrocyte and leukocyte counts, polymorphonuclear percentage · Solid specimens: crushed using a mechanic apparatus · Gram and auramine staining· Cultures at 37°C on Columbia sheep blood agar (aerobically and anaerobically for 5 days), chocolate agar supplemented with IsoVitaleX (with 5% CO2 for 5 days), brain heart infusion broth (anaerobically for 15 days with subcultures done after 10 days on the same agar media, even if aspect was not cloudy).· Mycobacterial culture : Lowenstein-Jensen and COLETSOS media, MGIT incubated for 3 months.- Molecular procedures· DNA manipulations pre- and post-PCR: in separate rooms with separate pipetting devices to prevent contamination of samples with foreign DNA. · Equipment used in pre-PCR steps: DNA-free and UV-irradiated. · DNA extraction based on Boom's method: QIAGEN kit and EZ1 BioRobot · Broad-range 16S rRNA gene amplification · Amplicons: sequenced in both directions on an ABIPRISM 3100 analyser (Applied Bio systems, COURTABOEUF, France). · Cloning experiments for several sequences in one sample· Analysis of sequence: GenBank using the BLASTN program through the website of the National Centre of Biotechnology Information.· Internal control PCR: b-actin gene· Real time PCR: for the detection of mycobacteria and gonococcal arthritis- Potential implications: We could have chosen, like the majority of the studies published to date, to compare our molecular method with another method of diagnosis (culture, histology). However, there is not currently gold standard and the diagnosis of osteoarticular infections generally rests on an accumulation of arguments. The rule of the expert group is to determine, with less possible error, if each patient included will be "infected". This methodology is close to daily clinical reality and trusted in physician who was treating the patient. If the study shows an advantage of the molecular biology versus classical methods in our groups it would then be justified to discuss the diagnosis diagram of osteoarticular infections.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Suspected diagnosis of osteoarticular infections included discitis, septic arthritis and prosthetic joint infection and control patients.

Criteria

Inclusion Criteria:

  • Patient are more than 18 years old
  • Patient who do not declined to have his medical records reviewed for research

Spondylodiscitis (S) group:

  • Patients suspected of Discitis and/or Vertebral Osteomyelitis is defined by the need of spinal biopsy in infectious context. Spinal biopsies will be justified by one or more clinical or imaging findings:
  • Clinical presentation
  • Spinal pain unrelieved by rest
  • Localized tenderness, Neurological deficits or limited range of motion
  • Fever > 38°C

    • Imaging findings (plain radiographs, MRI or CT):
  • Erosions of end plates on adjacent vertebral bodies
  • Decreased height of the intervertebral disk
  • Presence of a nonvascularized zone suggesting presence of pus or necroses in intervertebral, epidural space or in paraspinal soft-tissues

Prosthetic Joint Infection (PJI) Group

Patients suspected of Prosthetic Joint Infection were defined by the need of surgical revision for diagnostic or therapeutic aiming in infectious context. This revision will be justified by one or more clinical, biological or imaging findings:

Clinical presentation

  • Persistent joint pain
  • Fever > 38°C
  • Erythematous, swollen, fluctuant, and/or tender surgical wound
  • Wound dehiscence
  • Limited range of joint motion

Biological findings

  • CRP > 10 mg/l
  • Synovial leukocytes count > 1500/mm3 and polymorphonuclear leukocytes > 65%

Imaging findings

  • Prosthesis loosening: Periprosthetic osteolysis, progressive peri-prosthetic edging
  • Scintigraphy by means of a technetium (Tc99m) scan, gallium citrate (Ga67) scan, or indium (In111)-labeled leukocyte showing fixation around the prosthesis.

Septic arthritis (SA) Group

  • Patients suspected of Septic arthritis without prosthesis were defined by the need of synovial punction and/or biopsy justified by one or more clinical, biological or imaging findings:

Clinical presentation

  • Acute joint pain and/or swelling
  • Adenopathy near inflammatory joint
  • Fever > 38°CBiological findings
  • WBC > 10 000/ mm3
  • CRP > 10 mg/l
  • Synovial leukocytes count > 2000/mm3 or polymorphonuclear leukocytes > 90%

Imaging findings:

  • Capsular and surrounding soft-tissues swelling
  • Synovial notch and/or demineralization
  • Periarticular Abscess

Exclusion criteria:

  • Patients already include.
  • Patient without health insurance
  • Antibiotic treatment before sampling does not constitute an exclusion criterion

Exclusion criteria for control groups:

Patient with one or more criteria:

  • Suspicion of concomitant infection defined by a fever >38°C and CRP > 10mg/l
  • Arthrosis treated by infiltration in the 6 months which preceding inclusion
  • Rapidly progressive arthrosis Prosthesis loosening or bone necrosis presumed to be aseptic
  • Patients with prior spinal instrumentation or surgery
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01193803

Locations
France
Hôpital LARIBOISIERE
Paris, France, 75010
Sponsors and Collaborators
Assistance Publique - Hôpitaux de Paris
Investigators
Principal Investigator: Beatrice BERCOT, MD,PhD Assistance Publique - Hôpitaux de Paris
  More Information

Publications:
Responsible Party: Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov Identifier: NCT01193803     History of Changes
Other Study ID Numbers: CRC076057, 297-08
Study First Received: April 1, 2010
Last Updated: May 30, 2014
Health Authority: France: Ministry of Health

Keywords provided by Assistance Publique - Hôpitaux de Paris:
Prosthetic Joint Infections
Vertebral Osteomyelitis
Septic arthritis
Molecular methods

Additional relevant MeSH terms:
Arthritis
Osteoarthritis
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases

ClinicalTrials.gov processed this record on August 21, 2014